Table 6.
Type of test | Experimental test system | Test substance | Exposure conditions | Result | WG considerations and conclusion | Reference |
---|---|---|---|---|---|---|
In vivo chromosomal aberration | BM cells of Chinese hamster (negative control: 8M + 8F, treated animals: 24M + 24F) |
Triazine amine CGA 150 829 tech. (97.6%) Vehicle: 0.5% CMC = negative control |
Preliminary tolerability test up to 5,000 mg/kg bw Gavage 0 & 3,200 mg/kg bw Sampling time: 16, 24 and 48 h after treatment |
3,200 mg/kg bw = highest applicable dose No increase in the number of metaphases with specific aberrations |
GLP compliant OECD 475 (1984) Slides of 5 males & 5 females selected for scoring 100 metaphases analysed/slide No information reported about the toxic effects observed in the preliminary tolerability test Major deviations from OECD TG 475 (2016) requirements Negative but no information on BM exposure |
Report 871187 |
BM: bone marrow; M: male; F: Female; CMC: Carboxymethylcellulose.